# Effects of Psilocybin in Post-Treatment Lyme Disease

> **NCT05305105** · PHASE1 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 20 (actual)

## Conditions studied

- Post-Treatment Lyme Disease
- Chronic Lyme Disease
- Lyme Disease, Chronic

## Interventions

- **DRUG:** Psilocybin

## Key facts

- **NCT ID:** NCT05305105
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-01
- **Primary completion:** 2024-10-26
- **Final completion:** 2025-04-07
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-08-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05305105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05305105, "Effects of Psilocybin in Post-Treatment Lyme Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05305105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*